According to a disclosure by the Hong Kong Stock Exchange on January 26, Beijing Acrobiosystems Biotech Co., Ltd. (Acrobiosystems, 301080.SZ) has submitted a listing application for the main board, with China Merchants Securities International acting as its sole sponsor. The prospectus reveals that Acrobiosystems is a global provider of life science tools and technical services, dedicated to empowering biopharmaceutical companies across the entire value chain from R&D and production to clinical application. According to data from Frost & Sullivan, in the global recombinant protein market, the company ranked first among all domestic Chinese suppliers and third among all global suppliers by 2024 revenue.